Efficacy of a Dehydrated Hydrogel Plug to Reduce Complications Associated With Computed Tomography–guided Percutaneous Transthoracic Needle Biopsy

Grage, Rolf A.; Naveed, Muhammad Atif; Keogh, Shane; Wang, Dongliang

doi:10.1097/rti.0000000000000247

Cited by 24 publications

(10 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…119), gelatin sponge (120), and self-expanding plugs (121)(122)(123) to reduce pneumothorax and/or the requirement for chest tubes after lung biopsies. Although these interventions show promise in small series, the current level of evidence is insufficient to advocate for a particular technique.…”

Section: Ae Rates and Thresholdsmentioning

confidence: 99%

Society of Interventional Radiology Quality Improvement Standards on Percutaneous Needle Biopsy in Adult and Pediatric Patients

Sheth

Baerlocher

Connolly

et al. 2020

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

Section: Ae Rates and Thresholdsmentioning

confidence: 99%

Society of Interventional Radiology Quality Improvement Standards on Percutaneous Needle Biopsy in Adult and Pediatric Patients

Sheth

Baerlocher

Connolly

et al. 2020

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

“…However, the prevailing method for pneumothorax prevention among STR members was an autologous blood patch. In addition, the use of hydrogel plugs was recently approved by the FDA for pneumothorax prevention ( 35 ). We believe that Korean radiologists should add blood patches and hydrogel plugs in their pallet of pneumothorax-prevention methods.…”

Section: Discussionmentioning

confidence: 99%

Practice Pattern of Transthoracic Needle Biopsy: 2016 Survey in the Members of Korean Society of Thoracic Radiology

Han

Beck

et al. 2017

Korean J Radiol

View full text Add to dashboard Cite

ObjectiveTo assess the current practice patterns of radiologists who perform transthoracic needle biopsy (TNB).Materials and MethodsAn email survey of 71 questions on TNB was sent to 240 members of the Korean Society of Thoracic Radiology. The answers to multiple-choice questions (n = 56) were analyzed.ResultsOf 60 respondents, 45% had 10 or more years of experience in chest radiology, and 70% had 5 or more years of experience in TNB. For the question on the most frequently used diagnostic method for lesions with high probability of being resectable-stage lung cancer, 70% of respondents answered that TNB is initially used, with or without bronchoscopy. In patients at high-risk of TNB-related complications, the proportion of the respondents who consistently declined TNB was only 5%. The number of rebiopsies was said to be increased; molecular analysis for an established target therapy (43.6%) and clinical trial of a new drug (28.2%) were the two most common reasons for it. The most popular needle type was the coaxial cutting needle (55%), and the popular guiding modality was conventional computed tomography (CT) (56.7%). In addition, 15% of respondents have encountered air embolism.ConclusionDespite high variation in how TNB is being performed in Korea, some patterns were noted. It is common for patients with resectable-stage lung cancer to undergo TNB prior to surgery. Rebiopsy is now more common than before, with personalized medicine as the most important reason for it. The most popular type of needle is the coaxial system; the most popular modality for guidance is still CT.

show abstract

“…Lung biopsies have among the highest rate of complications of all radiologic procedures with the main associated adverse event being pneumothorax, reported in over 50% of patients in some series. However, the incidence of this potential complication can be considerably reduced through the use of a tract sealant system or blood patch (34)(35)(36). The vast majority of patients suffering from a pneumothorax can be treated with oxygen and observation.…”

Section: Tissue Procurement Practices and Techniquesmentioning

confidence: 99%

Practical Considerations Relating to Routine Clinical Biomarker Testing for Non–small Cell Lung Cancer: Focus on Testing for RET Fusions

et al. 2021

View full text Add to dashboard Cite

For patients with advanced non–small cell lung cancer, genomic profiling of tumors to identify potentially targetable alterations and thereby inform treatment selection is now part of standard care. While molecular analyses are primarily focused on actionable biomarkers associated with regulatory agency-approved therapies, there are a number of emerging biomarkers linked to investigational agents in advanced stages of clinical development will become approved agents. A particularly timely example is the reported data and US Food and Drug Administration approval of highly specific small molecule inhibitors of the proto-oncogene tyrosine-protein kinase receptor RET indicate that testing for tumor RET gene fusions in patients with NSCLC has become clinically important. As the number of biomarkers to be tested in NSCLC grows, it becomes increasingly important to optimize and prioritize the use of biopsy tissue, in order to both continue to allow accurate histopathological diagnosis and also to support concurrent genomic profiling to identify perhaps relatively uncommon genetic events. In order to provide practical expert consensus guidance to optimize processes facilitating genomic testing in NSCLC and to overcome barriers to access and implementation, a multidisciplinary advisory board was held in New York, on January 30, 2019. The panel comprised physicians involved in sample procurement (interventional radiologists and a thoracic surgeon), surgical pathologists specializing in the lung, molecular pathologists, and thoracic oncologists. Particular consideration was given to the key barriers faced by these experts in establishing institutional genomic screening programs for NSCLC. Potential solutions have been devised in the form of consensus opinions that might be used to help resolve such issues.

show abstract

Efficacy of a Dehydrated Hydrogel Plug to Reduce Complications Associated With Computed Tomography–guided Percutaneous Transthoracic Needle Biopsy

Abstract: These data show that the deployment of a hydrogel plug after a computed tomography-guided lung biopsy significantly reduced the rate of chest tube insertion along with a reduced length of hospital stay.

Cited by 24 publications

References 17 publications

Society of Interventional Radiology Quality Improvement Standards on Percutaneous Needle Biopsy in Adult and Pediatric Patients

Society of Interventional Radiology Quality Improvement Standards on Percutaneous Needle Biopsy in Adult and Pediatric Patients

Practice Pattern of Transthoracic Needle Biopsy: 2016 Survey in the Members of Korean Society of Thoracic Radiology

Practical Considerations Relating to Routine Clinical Biomarker Testing for Non–small Cell Lung Cancer: Focus on Testing for RET Fusions

Contact Info

Product

Resources

About